Dexmal, a Chinese firm developing embodied AI for robot control, is reportedly seeking a $3 billion valuation in an ongoing funding round. While the specific amount raised is undisclosed, this round follows previous investments led by Alibaba Group Holding. The company aims to leverage this capital to advance its position in China's rapidly growing humanoid robotics sector, which is supported by significant government investment and aims for global leadership within five years.